Neovascular AMD: Impact of Dosing Regimens and Residual Retinal Fluid on Long-term Outcomes
Break
Welcome
The Survivor Mentality
Panel Discussion: How We Survived and What Positive Changes Have Come Out of Our Experiences
NETWORKING & REFRESHMENTS IN THE EXHIBIT HALL
What’s New for 2021? A post-COVID financial check-up including what do best-of-class practices need to know and prepare for and what changes will affect the bottom line. This dynamic duo will present a discussion and checklist to navigate the remainder of 2021 and beyond.
Healthcare Law in the New Normal: What Just happened? Telehealth View, Human Resources Post-COVID-19, Physician Contracting and How Salary Addendums were Handled
Work Smarter Not Harder: The Team Approach Using Staff and Technology at the Highest Level
Retina360: Advances in the Management of Retinal Disease
Disruptive Innovations Symposium: New Technology IOLs, Diagnostics and Drug Delivery
Exploring the Role of Angiopoietins in Retinal Diseases
Welcome & Announcements
Mechanisms in the Development and Progression of ERM using Advanced Imaging
Challenges in Tele-retinal Screening for Diabetic Retinopathy
Using Imaging to Improve Your Uveitis Game
An Update on OCT and Imaging in the Home
Tele-retina in the Management of AMD and Retinal Vascular Diseases
REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL
Plasmin Kallikrein Inhibition
Discussion
TIE2, Integrin, and VEGF Pathways and Retinal Diseases
Biosimilars and Retinal Diseases
Gene Therapy for Retinal Vascular Disease
Complement Inhibition and Dry AMD
Neuroprotection, Oxidative Stress Reduction, and Toxic Byproduct Accumulation Reduction in Dry AMD
HTRA1 Inhibition, Inflammasome Regulation, and Other Approaches in Dry AMD
Tyrosine Kinase Inhibition and Wet AMD
Lengthening the Treatment Interval in Age-related Macular Degeneration: Current Status and Insights
Practical Training in Equipment, Technology, and Insurance
Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.
Revelations in Retinal Vein Occlusion Management – What’s New?
Announcements
The Role of Fluid in Exudative AMD
Sustained Delivery of Anti-VEGF Therapy for nAMD
Safety Update on Anti-VEGF Treatment
Outcomes of Anti-VEGF Treatment for CNV in Fellow Eyes of Previously Treated Patients with Wet AMD
Complement Inhibition for Geographic Atrophy
Non-neovascular AMD with Fluid: Exudation vs. Transudation in “Dry” AMD
Ang-2 Inhibition for Neovascular AMD
Gene and Cell Therapy Strategies for Neovascular and Atrophic AMD
Panel Discussion
Diabetic Macular Edema Management in 2021: What’s New?
Neuromyelitis Optica Spectrum Disorder (NMOSD): Novel Therapeutic Options to Manage a Difficult-to-Diagnose Disorder
Moving Diabetic Retinopathy Treatment Forward by Early Intervention to Improve Long-term Outcomes
Classification and Treatment of Macular Telangiectasia: Update on Treatment
Recognition of PAMM in Retinal Vascular Occlusions: Why Does it Matter?
Top 5 Lessons Learned from the SCORE2 Study
Organization of the Retinal Capillary Plexus and New Predictive Biomarkers in CRVO
Diabetic Retinal Neurodegeneration: Should We Redefine Diabetic Retinopathy?
A Case-based Review of the Latest DRCR Retina Network Trials
Diabetic Retinopathy Regression: Disease Modification or Just a Pretty Picture
When to Observe and When to Treat in DME: Applying Lessons from Clinical Trials
Ang-2 Inhibition for Diabetic Macular Edema and Diabetic Retinopathy
Introduction
Debate: Advanced NPDR Should be Treated with Anti-VEGF Therapy
Panel Discussion: How I am Currently Managing My Retinal Vascular Disease Patients
The Tie2 Pathway: A New Approach in Retinal Disease?
Early Identification and Management Strategies for Patients With DME
The Aqueous Humor Liquid Biopsy for Retinoblastoma
Genetic Testing 101
Rumors about Tumors: Top Do Not Miss Tips from an Ocular Oncologist
ROP: Where Are We Today
Melanoma: Management in 2021
Subretinal Gene Therapy and Surgical Lessons Learned
Pediatric Surgery What I Have Learned
What I Have Learned from the COVID-19 Pandemic
Infectious Retinitis
Anti-VEGF in ROP
My Favorite Cases of 2020
Therapeutic Targeting of the Complement System in Geography Atrophy
Educational Program & Breakfast
Congenital Optic Nerve Anomalies Surgical Management
Perfluorocarbon Liquids in Retinal Detachment Repair: Pearls and Pitfalls
Management of Challenging Macular Holes: A Conceptual Approach
New Innovations in Surgical Sterility
Update on New Surgical Instruments
Interactive Panel: Vitreoretinal Surgical Pearls
Best Cases of 2020
Meeting Concludes
Back to Top